Ads
related to: stanford oncology clinical trials
Search results
Results from the WOW.Com Content Network
He is an oncologist and cancer pharmacologist, and has served as a faculty member at Stanford University since 1979. His research spans basic, translational, and clinical research and investigates the mechanisms of drug resistance and the development of new anticancer therapies.
The Stanford Cancer Institute was founded in 2004 and first received NCI-designation as a clinical cancer center in 2007. In 2016, it received its comprehensive cancer center designation. [3] [1] In 2022, the Stanford Cancer Institute received its comprehensive cancer center designation renewal.
The trial was conducted at the Stanford Center for Cancer Cell Therapy, which modified the chimeric antigen receptor T cell (CAR-T) to identify B-cell prolymphocytic leukemia and B-cell lymphoma. [ 34 ] [ 35 ] In 2022, Mackall was awarded $11.9 million from the California Institute of Regenerative Medicine to lead a clinical trial using T cells ...
In 2003, she was given a Merit Award from the American Society of Clinical Oncology. [2] She is the lead investigator on the ECOG-ARIN clinical trials group at Stanford, and was given a Young Investigator Award from ECOG-ARIN in 2015. [4] She serves on the board of directors of the International Association for the Study of Lung Cancer. [5]
He earned an M.D. from Stanford University in 1985 and a Ph.D. from Stanford in 1991. [3] As a medical student at Stanford, Maloney was a member of the lab of Ronald Levy. [4] He completed an internship and residency in internal medicine at Brigham and Women's Hospital and a fellowship in oncology at Stanford University Medical Center. [3]
Steven N. Goodman (born 1954) is an American Professor of Epidemiology and Population Health and of Medicine at the Stanford School of Medicine. [1] He has extensively contributed to foundations of scientific and statistical inference within the biosciences, and in 1999 he coined the term "p-value fallacy". [2]
She believes that breast cancer tumors have genetic differences that respond differently to treatments. [11] In 2019, she combined molecular analysis and historical clinical data to create the largest breast cancer cohort. In this cohort she found four groups of tumors that occur later in life, up to 20 years after the initial cancer diagnosis.
The Stem Cell Research Building is the first of the planned Stanford Institutes of Medicine. In addition to research facilities, it houses offices for faculty from the Stanford Cancer Center and "hotel space" offices for visiting researchers. [9]
Ads
related to: stanford oncology clinical trials